BioNTech CEO Uğur Şahin and Pfizer CEO Albert Bourla both say that their vaccine is likely to be effective against severe disease resulting from the Omicron variant. (Reuters) COVID-19 vaccine, Variants of SARS-CoV-2COVID-19 pandemic link embed save